Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

6.29USD
1:09pm EDT
Change (% chg)

$0.09 (+1.45%)
Prev Close
$6.20
Open
$6.11
Day's High
$6.33
Day's Low
$6.11
Volume
34,748
Avg. Vol
67,523
52-wk High
$8.97
52-wk Low
$3.55

Latest Key Developments (Source: Significant Developments)

Rockwell Medical Q2 loss per share $0.14
Wednesday, 9 Aug 2017 04:13pm EDT 

Aug 9 (Reuters) - Rockwell Medical Inc ::Rockwell medical reports second quarter results.Q2 loss per share $0.14.Q2 sales $13.2 million.  Full Article

Rockwell Medical, Baxter Healthcare settle arbitration
Thursday, 29 Jun 2017 05:19pm EDT 

June 29 (Reuters) - Rockwell Medical Inc ::Rockwell Medical Inc - on June 23, 2017, co and Baxter Healthcare Corporation settled the arbitration related to claims made by each party.Rockwell Medical - claims alleging that other party had materially breached exclusive distribution agreement dated October 2, 2014 between co, Baxter.Rockwell Medical Inc - no payments were made by either party in connection with settlement - SEC filing.Rockwell Medical Inc - in connection with settlement, on June 23, company and Baxter entered into first amendment to exclusive distribution agreement.Rockwell Medical Inc - also in connection with settlement, on June 23, 2017, company and baxter entered into a first amendment to investment agreement.Rockwell Medical Inc - revised distribution agreement modifies pricing schedule to provide more "competitive" pricing to Baxter.  Full Article

Rockwell Medical reports Q1 loss per share $0.09
Tuesday, 9 May 2017 04:01pm EDT 

May 9 (Reuters) - Rockwell Medical Inc :Rockwell Medical reports first quarter results.Q1 loss per share $0.09.Qtrly sales were $14.6 million, or $1.0 million higher than Q1 2016, primarily due to higher domestic sales.  Full Article

Rockwell Medical Q4 loss per share $0.10
Wednesday, 15 Mar 2017 04:01pm EDT 

Rockwell Medical Inc : Rockwell medical reports fourth quarter results . Q4 loss per share $0.10 . Qtrly sales were $13.4 million, or $0.7 million lower than q4 2015 . "have advanced our clinical development work for triferic in both china and india markets" .Q4 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.  Full Article

Richmond Brothers and Mark Ravich respond to Rockwell Medical lawsuit
Thursday, 9 Mar 2017 09:00am EST 

Rockwell Medical Inc : Richmond Brothers Inc and Mark Ravich respond to Rockwell Medical Inc Lawsuit .Richmond Brothers, Inc - "Believe Rockwell's allegations are baseless and untrue".  Full Article

David Richmond reports 10.8 pct stake in Rockwell Medical
Tuesday, 21 Feb 2017 09:13am EST 

Rockwell Medical Inc : David Richmond reports 10.8 percent stake in Rockwell Medical Inc as of Feb 20 - sec filing . David Richmond - purchased Rockwell Medical Inc's shares based on belief that shares, when purchased, were undervalued . David Richmond-believe that Rockwell Medical remains significantly undervalued in large part due to poor corporate governance practices,operational missteps by management team,board .David richmond-intend to engage in discussions with rockwell medical's management, board, stockholders,other interested parties regarding capital allocation,strategic plans.  Full Article

Rockwell Medical updates progress on Calcitriol commercial launch
Tuesday, 21 Feb 2017 09:00am EST 

Rockwell Medical Inc : Rockwell Medical updates progress on calcitriol commercial launch . Rockwell Medical Inc - FDA has requested that company resubmit application for new contract manufacturer as a prior approval supplement . Rockwell Medical Inc - FDA has requested that company pay a fee for agency review .Rockwell Medical Inc - company anticipates calcitriol to become commercially available in u.s. Market in approximately 4-6 months.  Full Article

Rockwell Medical reports Q3 loss per share $0.09
Monday, 7 Nov 2016 04:01pm EST 

Rockwell Medical Inc : Rockwell Medical reports third quarter results .Q3 loss per share $0.09.  Full Article

Rockwell Medical enters into license agreement with ARAM Medical
Tuesday, 16 Aug 2016 08:00am EDT 

Rockwell Medical Inc: Rockwell Medical enters into exclusive license agreement with ARAM Medical to commercialize Triferic® in Saudi Arabia, Egypt and Middle East territories . ARAM will also assume responsibility for all clinical and regulatory expenses for territories . Rockwell retains manufacturing responsibilities for both Triferic and Calcitriol . Commercial product availability expected within about 12 months in Saudi Arabia and 12 to 18 months in Egypt and all other territories . ARAM medical will become exclusive distributor for Triferic and Calcitriol in 13 countries .ARAM will pay to Rockwell upfront licensing fees, a "high double-digit royalty on product sales".  Full Article

Rockwell Medical Inc - qtrly sales were $13.5 mln, or 3.8% higher than Q2 2015
Monday, 8 Aug 2016 04:01pm EDT 

Rockwell Medical Inc :Qtrly sales were $13.5 million, or 3.8% higher than q2 2015..  Full Article

BRIEF-Rockwell Medical Q2 loss per share $0.14

* Q2 sales $13.2 million Source text for Eikon: Further company coverage: